How much funding has Cytek Biosciences raised?

Cytek Biosciences has raised $24.3M in total funding, most recently a Series C round.

Who are Cytek Biosciences's investors?

Cytek Biosciences's investors include Easy Prosperity, F-Prime Capital, Eight Roads Ventures, RA Capital Management, Northern Light Ventures, 3E Bioventures Capital.

Where is Cytek Biosciences headquartered?

Cytek Biosciences is headquartered in Fremont, United States.

What industry is Cytek Biosciences in?

Cytek Biosciences operates in Biotech, Manufacturing.

How many employees does Cytek Biosciences have?

Cytek Biosciences has 501-1000 employees.

Cytek Biosciences

IPO

Designing, Building and Supporting Flow Cytometers

Public · Fremont, United States · $24.3M raised

Biotech

Manufacturing

Headquarters: Fremont
Employees: 501–1000
Business Model: B2B
Total Funding: $24.3M

Last Round: $12.0M Series CSep 2018
Rounds: 3
Type: Public

About

Cytek Biosciences designs, builds, and supports full spectrum flow cytometry instruments for life sciences research and clinical applications, headquartered in Fremont, California. Its core product lines — the Aurora, Northern Lights, and Borealis systems — use patented full spectrum profiling technology to analyze more cell markers simultaneously than conventional flow cytometers, serving academic, pharmaceutical, and biotech customers worldwide. Beyond instruments, Cytek offers reagents, analysis software, training, and validation services, and operates subsidiaries in the Netherlands, Japan, and China to support its global customer base.

Summary

Cytek Biosciences is a Biotech company based in Fremont, United States. It has raised $24.3M in total across 3 rounds, most recently a $12.0M Series C round in Sep 2018. Investors include Easy Prosperity, F-Prime Capital and Eight Roads Ventures.